Isansys Lifecare is a pioneering medical technology company founded in 2010, dedicated to transforming patient care through innovation and cutting-edge technology. Isansys Lifecare Europe GmbH, based near to Berlin is a subsidiary of Isansys Lifecare Ltd in the UK. Isansys Lifecare India Pvt. Ltd is a joint venture established in Bangalore to access and gain from the economies of scale of the vast Indian market. Isansys has established itself as a global leader in wireless patient monitoring solutions and actively collaborates with healthcare providers worldwide, aiming to improve patient care, enable early intervention, and enhance healthcare efficiency and patient safety. Its partnerships with leading hospitals and academic institutions underscore its commitment to advancing healthcare delivery and patient outcomes.
At the heart of Isansys' mission is the Patient Status Engine (PSE), the world’s first medically certified, intelligent, end-to-end patient monitoring platform. The PSE uses all wireless technology to collect clinical vital signs and physiological data from patients of all ages and enables continuous monitoring of patients both in hospital and as ambulatory patients at home. The PSE is a powerful bedside automation system utilising real-time data analytics to provide actionable insights and empower healthcare professionals to make better and faster clinical decisions.
Isansys focuses on delivering patient-centered technologies and data-driven methods to hospitals and healthcare organisations globally. By offering vital tools that improve care and clinical performance, Isansys’ technology saves money and enhances patient safety. The company is committed to early detection of deteriorating health conditions and prompt intervention, thereby improving patient outcomes and reducing overall costs of care.
As a pioneer in the industry, Isansys has achieved notable regulatory milestones, becoming the first UK manufacturer to obtain the UKCA mark for wearable sensors and remote patient monitoring platforms in June 2022. The PSE platform holds comprehensive CE, UKCA and FDA certifications, underscoring its adherence to the highest global standards.
Ensuring the safety, connectivity, and monitoring of every patient, regardless of location, is central to Isansys' mission. Through innovative patient monitoring technologies and smarter predictive indicators, Isansys strives to transition patients from higher-cost to lower-cost care settings, including at-home monitoring.